Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Best and Worst Investments of 2012

By Ben Steverman - 2012-12-12T21:04:13Z

Photograph by Mark Harmel/Getty Images

Company Symbol % Change
2 of 18

Best U.S. Large-Cap Stock

Regeneron Pharmaceuticals

+219%

Among the good news for Regeneron (REGN) shareholders were strong sales for a treatment for eye diseases. Total revenue jumped fourfold last quarter. The Tarrytown, N.Y.-based company also won approval for a chemotherapy drug and is developing drugs to treat rheumatoid arthritis and high cholesterol.

Universe and criteria: 358 stocks on U.S. exchanges with market capitalizations of more than $10 billion.

Advertisement